In my recent research, I've delved into the role of personalized medicine in treating neuroblastoma, a type of cancer that mostly affects children. Personalized medicine tailors treatment based on the genetic makeup of the cancer, offering a more effective approach. This targeted therapy means that the treatment can specifically attack cancer cells, reducing harm to healthy cells and potentially leading to better outcomes. The hope is that personalized medicine will not only increase survival rates but also reduce the long-term side effects often experienced by survivors. It's a promising field that could revolutionize how we treat neuroblastoma and other cancers.